Previous 10 | Next 10 |
Amedisys, Inc. (AMED) Q3 2021 Earnings Conference Call November 03, 2021 11:00 AM ET Company Participants Nick Muscato – Senior Vice President-Finance Paul Kusserow – Chairman and Chief Executive Officer Chris Gerard – President and Chief Operating Officer Scott Ginn ...
Amedisys (NASDAQ:AMED): Q3 Non-GAAP EPS of $1.53 beats by $0.16; GAAP EPS of $1.37 beats by $0.02. Revenue of $553.4M (+1.7% Y/Y) misses by $14.87M. Press Release For further details see: Amedisys EPS beats by $0.16, misses on revenue
BATON ROUGE, La., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2021. Three-Month Periods Ended September 30, 2021 and 2020 Net service revenue increased...
BATON ROUGE, La., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, and Chris Gerard, President and Chief Op...
BATON ROUGE, La., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has closed on its acquisition of regulatory assets that allow the Company to establish home health care centers to fully service and expan...
Three new services will create a continuum of care to empower patient choice, lower costs and improve results Henry Ford Health System announced a new partnership today with the nation’s leading operator of high-acuity home care, Contessa , an Amedisys company (NA...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
On a lackluster day for the major averages, dine-in restaurant stocks provided an appetizing meal for investors on Friday. The sector got a boost from a bullish analyst note, sparking gains in Dave & Buster's Entertainment (NASDAQ:PLAY), BJ's Restaurants (NASDAQ:BJRI), Cheesecake Factory ...
UBS analyst Andrew Mok has initiated coverage on HCA Healthcare (NYSE:HCA) with a Buy rating and price target (PT) of $312. HCA is in a positive earnings revision cycle with strong demand, market share gains and free cash flow likely to drive EBITDA above consensus 2022 estimates, believes an...
Amedisys (NASDAQ:AMED) to acquire regulatory assets that allow the company to establish home health care centers to fully service and expand the Charlotte and Raleigh, N.C. markets. Under the agreement, company will acquire the right to expand certified home health ca...
News, Short Squeeze, Breakout and More Instantly...
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 Net service revenue increased $38.2 million to...
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Amedisys, Inc. (NASDAQ: AMED) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.74% on the day to $95.23. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates thr...